These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 33908355)

  • 1. Double standards redux.
    Macklin R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing vaccines in the time of Covid: The changing landscape.
    Cash RA
    Indian J Med Ethics; 2021; VI(2):1-4. PubMed ID: 33908357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled trials of Covid-19 vaccines - Are they still ethical?
    Ortiz-Millán G
    Indian J Med Ethics; 2021; VI(2):1-8. PubMed ID: 33908358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problematic Covid-19 vaccine trials in times of vaccine nationalism.
    Ravinetto R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.
    Holm S
    J Med Ethics; 2020 Sep; 46(9):569-573. PubMed ID: 32616623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Xia S; Zhang Y; Wang Y; Wang H; Yang Y; Gao GF; Tan W; Wu G; Xu M; Lou Z; Huang W; Xu W; Huang B; Wang H; Wang W; Zhang W; Li N; Xie Z; Ding L; You W; Zhao Y; Yang X; Liu Y; Wang Q; Huang L; Yang Y; Xu G; Luo B; Wang W; Liu P; Guo W; Yang X
    Lancet Infect Dis; 2021 Jan; 21(1):39-51. PubMed ID: 33069281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical limits to placebo use and access to Covid-19 vaccines as a human right.
    Greco DB
    Indian J Med Ethics; 2021; VI(2):1-14. PubMed ID: 33908350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo control in Covid-19 trials: A missed opportunity for international guidance.
    Wiesing U; Ehni HJ
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns.
    Zellweger RM; Wartel TA; Marks F; Song M; Kim JH
    Expert Rev Vaccines; 2020 Aug; 19(8):691-698. PubMed ID: 32838605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccines: ethical framework concerning human challenge studies.
    Calina D; Hartung T; Docea AO; Spandidos DA; Egorov AM; Shtilman MI; Carvalho F; Tsatsakis A
    Daru; 2020 Dec; 28(2):807-812. PubMed ID: 32851596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solidarity across borders: A pragmatic need for global COVID-19 vaccine equity.
    Obinna DN
    Int J Health Plann Manage; 2022 Jan; 37(1):21-29. PubMed ID: 34585430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2: vaccines in the pandemic era.
    Li DD; Li QH
    Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
    Al-Kassmy J; Pedersen J; Kobinger G
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.